CENPO and prostate adenocarcinoma: The results obtained show that CENPO was up-regulated in most cancers (Fig. 2C), including BLCA, BRCA, CESC, CHOL, COAD, ESCA, GBM, HNSC, LIHC, LUAD, LUSC, prostate adenocarcinoma (PRAD), READ, STAD, and UCEC.